TY - JOUR
T1 - Laparoscopic partial nephrectomy in the treatment of renal cell carcinoma
T2 - A minimally invasive means to nephron preservation
AU - Blitstein, Jeffrey
AU - Ghavamian, Reza
PY - 2008
Y1 - 2008
N2 - With the advent of cross-sectionai imaging, the incidence of asymptomatic detected small renal masses, 'incidentalomas', has increased in the past 20 years. Recent studies have demonstrated that patients with renal masses have worse renal function at baseline and have more comorbidities than the general population. Nephron-sparing surgery allows for maximal preservation of functioning nephrons with comparable oncologic outcomes. Recently, laparoscopic partial nephrectomy has emerged as a minimally invasive nephron-sparing surgical option for treating the appropriately selected renal mass. While open-partial nephrectomy has undisputedly become standard of care for the management of the small renal mass (<4 cm), laparoscopic partial nephrectomy is becoming the preferred option for select patients in institutions in which advanced laparoscopic experience is available.
AB - With the advent of cross-sectionai imaging, the incidence of asymptomatic detected small renal masses, 'incidentalomas', has increased in the past 20 years. Recent studies have demonstrated that patients with renal masses have worse renal function at baseline and have more comorbidities than the general population. Nephron-sparing surgery allows for maximal preservation of functioning nephrons with comparable oncologic outcomes. Recently, laparoscopic partial nephrectomy has emerged as a minimally invasive nephron-sparing surgical option for treating the appropriately selected renal mass. While open-partial nephrectomy has undisputedly become standard of care for the management of the small renal mass (<4 cm), laparoscopic partial nephrectomy is becoming the preferred option for select patients in institutions in which advanced laparoscopic experience is available.
KW - Kidney
KW - Laparoscopy
KW - Nephrectomy
KW - Renal cell carcinoma
UR - http://www.scopus.com/inward/record.url?scp=47249130010&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=47249130010&partnerID=8YFLogxK
U2 - 10.1586/14737140.8.6.921
DO - 10.1586/14737140.8.6.921
M3 - Review article
C2 - 18533801
AN - SCOPUS:47249130010
SN - 1473-7140
VL - 8
SP - 921
EP - 927
JO - Expert Review of Anticancer Therapy
JF - Expert Review of Anticancer Therapy
IS - 6
ER -